Theresa Oney, MD
Physical Medicine & Rehabilitation · Grosse Pointe, MINPI 1629164397
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 77.6% of it on its own, with 16 other manufacturers making up the rest. Among physical medicine & rehabilitation clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $50.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Scilex Pharmaceuticals Inc.$290
- Averitas Pharma Inc.$213
- Ferring Pharmaceuticals Inc.$153
- Collegium Pharmaceutical, Inc.$131
- Ipsen Biopharmaceuticals, Inc$90
- plus $280 from 11 others
What the payments were for
- Consulting fees$1,23824%
- Travel & lodging$1,72233%
- Food & beverage$2,21343%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $4,015 |
| Scilex Pharmaceuticals Inc. | 14 | $290 |
| Averitas Pharma Inc. | 8 | $213 |
| Ferring Pharmaceuticals Inc. | 10 | $153 |
| Collegium Pharmaceutical, Inc. | 6 | $131 |
| Ipsen Biopharmaceuticals, Inc | 1 | $90 |
| Merz Pharmaceuticals, LLC | 1 | $82 |
| Pfizer | 2 | $29 |
| Novo Nordisk | 2 | $27 |
| Virtus Pharmaceuticals LLC | 2 | $25 |
| Mannkind Corporation | 2 | $23 |
| Biodelivery Sciences International, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| GRT US Holding, Inc. | 1 | $13 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$236
How this compares
$5,173 in reported general payments places this provider in the 90th percentile of 469 physical medicine & rehabilitation providers in Michigan.
See all physical medicine & rehabilitation providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxymorphone Hcl ErOxymorphone Hcl | 36 | $48,990 |
| OxycontinOxycodone Hcl | 13 | $17,204 |
| BelbucaBuprenorphine Hcl | 19 | $9,454 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 256 | $6,045 |
| MovantikNaloxegol Oxalate | 13 | $5,440 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 395 | $4,901 |
| Buprenorphine | 16 | $2,416 |
| Gabapentin | 238 | $1,607 |
| Tramadol Hcl ErTramadol Hcl | 32 | $1,312 |
| Naloxone Hcl | 16 | $1,138 |
| Lidocaine | 28 | $954 |
| Pregabalin | 70 | $716 |
| Oxycodone Hcl | 47 | $691 |
| Naproxen | 44 | $616 |
| Cyclobenzaprine Hcl | 103 | $465 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $131 | $9,45419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 469 physical medicine & rehabilitation providers in Michigan.
Other physical medicine & rehabilitation in Grosse Pointe
- Edward DabrowskiRoseville$167K
- Erika ErlandsonAnn Arbor$54K
- Gianna Maria RodriguezAnn Arbor$41K
- Mathew SaffarianEast Lansing$24K
- Jason PeterTroy$20K
- David WiersemaSaginaw$17K
- Satyum ParikhWarren$11K
- Reginald KapteynMuskegon$11K
- Emily GladstoneGrand Rapids$10K
- In YoonDearborn$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.